Digital Look

Welcome to Digital Look++,
you are not logged in

Gilead Sciences Inc. (GILD)

$ 147.64

By Abigail Townsend

Date: Monday 23 Feb 2026

(Sharecast News) - Shares in Arcellx soared on Monday, after the US biotech agreed to be taken over by Gilead Sciences in a near $8bn deal.

GSK's ViiV says trial indicates HIV shot as effe...	23-Feb-2023	ShareCast
Gilead raises 2020 forecasts after Covid-19 surg...	11-Jan-2021	ShareCast
FDA grants EUA for Eli Lilly treatment in conjun...	20-Nov-2020	ShareCast
WHO advises against prescribing remdesivir for C...	20-Nov-2020	ShareCast
Eli Lilly halts late stage trial into Covid-19 a...	27-Oct-2020	ShareCast

CEO pay soars while workers' pay stalls	01-Apr-2011	USA Today
Biz Break: In Tesla, the next American auto icon...	01-Apr-2011	BayArea.com
Biz Break: Apple iPod speculation: New iPod touc...	31-Aug-2010	BayArea.com
Glaxo and Pfizer Join Forces to Develop and Mark...	17-Apr-2009	New York Times
Gilead to buy CV Therapeautics for $1.4 billion	13-Mar-2009	BayArea.com

Text size: increase text sizedecrease text size ...	13-Mar-2009	Chicago Tribune
Stocks extend their gains on retail news	12-Mar-2009	USA Today
Big drug makers may seek to fill holes in roster	25-Feb-2009	Intl Herald Tribune
Long Slump May Mean Drug Stocks Are Bargains	01-Mar-2008	New York Times
Stocks soar after tame report on inflation	15-Jun-2007	BayArea.com

Investment Tips for Aggressive Traders! July 12,...	12-Jul-2006	Marketwired
(OTC: TAOL) Gets Target Price of $2.75 From Mark...	20-Jun-2006	Marketwired
(OTC: MTNA) Applauds U.S. Dept. of Transportatio...	01-Jun-2006	Marketwired
Fantastic Month for Stock Alerts as 100% Are Pro...	09-May-2006	Marketwired
Seven Summits Research Releases Comments on GILD...	17-Feb-2006	PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.